ResMed Aktie
WKN DE: 895878 / ISIN: US7611521078
25.04.2024 23:24:20
|
Resmed Inc Q3 Profit Increases, beats estimates
(RTTNews) - Resmed Inc (RMD) released earnings for its third quarter that increased from last year and beat the Street estimates.
The company's bottom line totaled $300.5 million, or $2.04 per share. This compares with $232.5 million, or $1.58 per share, in last year's third quarter.
Excluding items, Resmed Inc reported adjusted earnings of $314.4 million or $2.13 per share for the period.
Analysts on average had expected the company to earn $1.91 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 7.2% to $1.197 billion from $1.117 billion last year.
Resmed Inc earnings at a glance (GAAP) :
-Earnings (Q3): $300.5 Mln. vs. $232.5 Mln. last year. -EPS (Q3): $2.04 vs. $1.58 last year. -Revenue (Q3): $1.197 Bln vs. $1.117 Bln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ResMed Inc.mehr Nachrichten
Analysen zu ResMed Inc.mehr Analysen
Aktien in diesem Artikel
ResMed Inc. | 227,70 | -0,44% |
|